The deal value is $17B. Together with the Millipore unit Merck acquired for $7.2B in 2010 (#msg-47249493), SIAL will create an imposing life-sciences “tools” business under the Merck KGaA umbrella.
A CC was held today at 8am ET.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”